Uruguay Central Bank Holds Interest Rate at 5.75% Amid Inflation and Oil Price Concerns 
BOJ Signals Possible Rate Hike as Middle East Tensions Fuel Inflation Concerns 
SpaceX IPO Hype Raises Questions as Many Major Stock Debuts Underperform Market 
Samsung to Invest $1.5 Billion in Vietnam Semiconductor Testing Plant by 2027 
European EV Sales Surge in April 2026 as Tesla and Chinese Automakers Gain Ground 
BOJ Governor Ueda Warns Oil Price Shock Could Trigger Persistent Inflation 
Huawei Chip Breakthrough Sparks Rally in Chinese Semiconductor Stocks 
Wall Street Futures Steady as AI Rally Offsets Middle East Tensions 
European Stocks Rise as AI Optimism Offsets U.S.-Iran Tensions 
Xiaomi Shares Drop After Weak Q1 Earnings Amid Rising Smartphone Costs 
Japan Falls to Third-Largest Global Creditor as China Overtakes in 2025 
Morgan Stanley Names Top AI Security and Data Center Stocks for 2026 
Macquarie Names Five Taiwan AI Stocks Set to Benefit From Data Center Growth in 2026 
Oil Prices Jump as U.S. Strikes in Iran Raise Fears Over Strait of Hormuz Supply Disruptions 
Australia Urged to Simplify Regulations to Revive IPO Market and Boost Innovation 
Lotte Biologics unveiled a landmark $3 billion partnership with Incheon's city government, Lotte Corporation, and Incheon Free Economic Zone (IFEZ) to establish major biotech production plants in Songdo. This monumental move accelerates the biotech giant's ambitious aim of a combined production capacity of 360,000 liters by 2030.
Lotte Biologics said on Tuesday, June 20, that the MOU is its first step into building the facilities in the region. As per Korea Joongang Daily, the other parties in the project are Lotte Corporation and the Incheon Free Economic Zone (IFEZ).
The contract signing ceremony was held at the IFEZ HQ in Songdo, and executives of the companies were present, including Lotte Biologics’ CEO, Richard Lee; IFEZ’s commissioner, Kim Jin Young; Lotte Corp. president, Lee Hun Ki; and Mayor of Incheon Metropolitan City, Yoo Jeong Bok.
The construction of the production facilities is part of the biotech firm’s plan to erect three new factories that will have a combined production facility of 360,000 liters by the year 2030. The plan was first unveiled in January this year.
The industrial complex will also be a place where the start-up, Bio-Venture Initiative, is expected to open a plant and facilitate possible technological cooperation. Lotte Biologics is planning a groundbreaking event for the construction, and this may happen soon.
This agreement highlights the enthusiastic response from Incheon Metropolitan City and Incheon Free Economic Zone regarding LOTTE BIOLOGICS’ intention to establish a major presence in Songdo,” Lotte Biologic’s chief executive officer said in a press release. “With the goal of commencing construction on the Mega Plant within the year, LOTTE BIOLOGICS will actively cooperate with Incheon Metropolitan City and Incheon Free Economic Zone to swiftly facilitate a land purchase agreement, with the enthusiastic support of LOTTE Corporation.”
Photo by: Lotte Biologics Newsroom
